Immunostaining for Galactose-deficient Immunoglobulin A is Not Specific for Primary Immunoglobulin A Nephropathy
Overview
Nephrology
Authors
Affiliations
Background: Primary immunoglobulin A nephropathy (IgAN) is characterized by IgA1-dominant or codominant glomerular deposits, postulated to be galactose deficient (Gd). However, glomerular IgA deposition can also occur in nonrenal diseases such as liver cirrhosis, psoriasis and inflammatory bowel disease ('secondary IgAN') or be an incidental finding in biopsies with other pathologies. A glomerulonephritis resembling IgAN can develop in patients with bacterial, mainly staphylococcal infections [staphylococcal infection-associated glomerulonephritis (SAGN)]. There are no specific histological features to distinguish between these, but differentiation is critical for appropriate management. The aim of this study was to investigate whether a recently described antibody to Gd-IgA1 (KM-55) could aid in differentiating primary IgAN from other conditions with glomerular IgA deposition, especially SAGN.
Methods: We performed a retrospective cohort study of patients who underwent kidney biopsy for clinical indications and were found to have glomerular IgA deposits.
Results: We evaluated 100 biopsies, including primary IgAN (n = 44), secondary IgAN (n = 27), SAGN (n = 13), incidental IgA deposition (n = 8) and lupus nephritis (n = 8). There was no difference in Gd-IgA staining intensity or the proportion of positive cases between primary and secondary IgAN. SAGN and cases with incidental IgA deposits had significantly lower Gd-IgA staining intensity than primary IgAN, but up to 69% of SAGN cases were positive (albeit weaker).
Conclusions: Gd-IgA staining is present not only in primary IgAN, but also in biopsies with secondary IgAN, SAGN and incidental IgA. Weak or negative staining may favor SAGN, especially in the setting of infection, or incidental IgA in the absence of nephritic symptoms or in the presence of other unrelated glomerular pathologies. However, positive staining for Gd-IgA alone is not specific enough for a diagnosis of primary IgAN.
C3 glomerulopathy associated with mycoplasma pneumoniae infection and positive IgA staining.
Duan Z, Li J, Cai G, Wang S, Tang X, Hou W BMC Nephrol. 2025; 26(1):85.
PMID: 39966764 PMC: 11837633. DOI: 10.1186/s12882-025-04010-9.
Umezawa Y, Aoki R, Ichikawa D, Suzuki Y, Suzuki T J Nephrol. 2025; .
PMID: 39946052 DOI: 10.1007/s40620-025-02213-9.
Crohn's disease-associated IgA nephropathy may prone to better renal outcome.
Yang Z, Xu X, Dong Y, Wu K, Zhao S, Zhang Y Int Urol Nephrol. 2024; 56(12):3815-3824.
PMID: 38904865 DOI: 10.1007/s11255-024-04106-5.
Secondary IgA Nephropathy and IgA-Associated Nephropathy: A Systematic Review of Case Reports.
Tota M, Baron V, Musial K, Derrough B, Konieczny A, Krajewska M J Clin Med. 2023; 12(7).
PMID: 37048809 PMC: 10094848. DOI: 10.3390/jcm12072726.
Tang X, Zheng J, Jiang X, Wan F, Hou X, Liu S Int Urol Nephrol. 2023; 55(8):2119-2129.
PMID: 36849627 DOI: 10.1007/s11255-023-03512-5.